Literature DB >> 25540418

ETS transcription factor ETV2 directly converts human fibroblasts into functional endothelial cells.

Rimpei Morita1, Mayu Suzuki2, Hidenori Kasahara2, Nana Shimizu2, Takashi Shichita3, Takashi Sekiya2, Akihiro Kimura2, Ken-ichiro Sasaki4, Hideo Yasukawa4, Akihiko Yoshimura1.   

Abstract

Transplantation of endothelial cells (ECs) is a promising therapeutic approach for ischemic disorders. In addition, the generation of ECs has become increasingly important for providing vascular plexus to regenerated organs, such as the liver. Although many attempts have been made to generate ECs from pluripotent stem cells and nonvascular cells, the minimum number of transcription factors that specialize in directly inducing vascular ECs remains undefined. Here, by screening 18 transcription factors that are important for both endothelial and hematopoietic development, we demonstrate that ets variant 2 (ETV2) alone directly converts primary human adult skin fibroblasts into functional vascular endothelial cells (ETVECs). In coordination with endogenous FOXC2 in fibroblasts, transduced ETV2 elicits expression of multiple key endothelial development factors, including FLI1, ERG, and TAL1, and induces expression of endothelial functional molecules, including EGFL7 and von Willebrand factor. Consequently, ETVECs exhibits EC characteristics in vitro and forms mature functional vasculature in Matrigel plugs transplanted in NOD SCID mice. Furthermore, ETVECs significantly improve blood flow recovery in a hind limb ischemic model using BALB/c-nu mice. Our study indicates that the creation of ETVECs provides further understanding of human EC development induced by ETV2.

Entities:  

Keywords:  ETV2; angiogenesis; direct conversion; endothelial cells

Mesh:

Substances:

Year:  2014        PMID: 25540418      PMCID: PMC4291653          DOI: 10.1073/pnas.1413234112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  Leukosialin (CD43) defines hematopoietic progenitors in human embryonic stem cell differentiation cultures.

Authors:  Maxim A Vodyanik; James A Thomson; Igor I Slukvin
Journal:  Blood       Date:  2006-06-06       Impact factor: 22.113

Review 2.  Pericellular proteases in angiogenesis and vasculogenesis.

Authors:  Victor W M van Hinsbergh; Marten A Engelse; Paul H A Quax
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-02-09       Impact factor: 8.311

Review 3.  Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression.

Authors:  Charles D Searles
Journal:  Am J Physiol Cell Physiol       Date:  2006-05-31       Impact factor: 4.249

4.  Vascular morphogenesis and differentiation after adoptive transfer of human endothelial cells to immunodeficient mice.

Authors:  Dag K Skovseth; Takeshi Yamanaka; Per Brandtzaeg; Eugene C Butcher; Guttorm Haraldsen
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

5.  Cathepsin L is required for endothelial progenitor cell-induced neovascularization.

Authors:  Carmen Urbich; Christopher Heeschen; Alexandra Aicher; Ken-ichiro Sasaki; Thomas Bruhl; Mohammad R Farhadi; Peter Vajkoczy; Wolf K Hofmann; Christoph Peters; Len A Pennacchio; Nasreddin D Abolmaali; Emmanouil Chavakis; Thomas Reinheckel; Andreas M Zeiher; Stefanie Dimmeler
Journal:  Nat Med       Date:  2005-01-23       Impact factor: 53.440

6.  Ex vivo pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapy.

Authors:  Ken-ichiro Sasaki; Christopher Heeschen; Alexandra Aicher; Thomas Ziebart; Joerg Honold; Carmen Urbich; Lothar Rossig; Ulrike Koehl; Masamichi Koyanagi; Annisuddin Mohamed; Ralf P Brandes; Hans Martin; Andreas M Zeiher; Stefanie Dimmeler
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-18       Impact factor: 11.205

7.  Vascularized and functional human liver from an iPSC-derived organ bud transplant.

Authors:  Takanori Takebe; Keisuke Sekine; Masahiro Enomura; Hiroyuki Koike; Masaki Kimura; Takunori Ogaeri; Ran-Ran Zhang; Yasuharu Ueno; Yun-Wen Zheng; Naoto Koike; Shinsuke Aoyama; Yasuhisa Adachi; Hideki Taniguchi
Journal:  Nature       Date:  2013-07-03       Impact factor: 49.962

8.  Repression of transcription by TSGA/Jmjd1a, a novel interaction partner of the ETS protein ER71.

Authors:  Julia Knebel; Luciano De Haro; Ralf Janknecht
Journal:  J Cell Biochem       Date:  2006-09-01       Impact factor: 4.429

9.  Generation of functional hemangioblasts from human embryonic stem cells.

Authors:  Shi-Jiang Lu; Qiang Feng; Sergio Caballero; Yu Chen; Malcolm A S Moore; Maria B Grant; Robert Lanza
Journal:  Nat Methods       Date:  2007-05-07       Impact factor: 28.547

10.  ER71 acts downstream of BMP, Notch, and Wnt signaling in blood and vessel progenitor specification.

Authors:  Dongjun Lee; Changwon Park; Ho Lee; Jesse J Lugus; Seok Hyung Kim; Elizabeth Arentson; Yun Shin Chung; Gustavo Gomez; Michael Kyba; Shuo Lin; Ralf Janknecht; Dae-Sik Lim; Kyunghee Choi
Journal:  Cell Stem Cell       Date:  2008-05-08       Impact factor: 24.633

View more
  72 in total

Review 1.  The short and long of noncoding sequences in the control of vascular cell phenotypes.

Authors:  Joseph M Miano; Xiaochun Long
Journal:  Cell Mol Life Sci       Date:  2015-05-29       Impact factor: 9.261

2.  Induction of hematopoietic and endothelial cell program orchestrated by ETS transcription factor ER71/ETV2.

Authors:  Fang Liu; Daofeng Li; Yik Yeung Lawrence Yu; Inyoung Kang; Min-Ji Cha; Ju Young Kim; Changwon Park; Dennis K Watson; Ting Wang; Kyunghee Choi
Journal:  EMBO Rep       Date:  2015-03-23       Impact factor: 8.807

Review 3.  Direct reprogramming into endothelial cells: a new source for vascular regeneration.

Authors:  Sangho Lee; Jin Eyun Kim; Brandon Al Johnson; Adinarayana Andukuri; Young-Sup Yoon
Journal:  Regen Med       Date:  2017-06-16       Impact factor: 3.806

4.  ETV-2 activated proliferation of endothelial cells and attenuated acute hindlimb ischemia in mice.

Authors:  Phuc Van Pham; Ngoc Bich Vu; Hoa Trong Nguyen; Thuy Thi-Thanh Dao; Ha Thi-Ngan Le; Lan Thi Phi; Oanh Thi-Kieu Nguyen; Ngoc Kim Phan
Journal:  In Vitro Cell Dev Biol Anim       Date:  2017-04-19       Impact factor: 2.416

Review 5.  Synthetic development: building mammalian multicellular structures with artificial genetic programs.

Authors:  Marco Santorelli; Calvin Lam; Leonardo Morsut
Journal:  Curr Opin Biotechnol       Date:  2019-05-23       Impact factor: 9.740

6.  FGF primes angioblast formation by inducing ETV2 and LMO2 via FGFR1/BRAF/MEK/ERK.

Authors:  Peng-Chieh Chen; Ya-Wen Hsueh; Yi-Hsuan Lee; Hung-Wen Tsai; Kuen-Jer Tsai; Po-Min Chiang
Journal:  Cell Mol Life Sci       Date:  2020-09-10       Impact factor: 9.261

7.  Direct Reprogramming of Human Dermal Fibroblasts Into Endothelial Cells Using ER71/ETV2.

Authors:  Sangho Lee; Changwon Park; Ji Woong Han; Ju Young Kim; Kyuwon Cho; Eun Jae Kim; Sangsung Kim; Shin-Jeong Lee; Se Yeong Oh; Yoshiaki Tanaka; In-Hyun Park; Hyo Jae An; Claire Min Shin; Shraya Sharma; Young-Sup Yoon
Journal:  Circ Res       Date:  2016-12-21       Impact factor: 17.367

8.  Topical tissue nano-transfection mediates non-viral stroma reprogramming and rescue.

Authors:  Daniel Gallego-Perez; Durba Pal; Subhadip Ghatak; Veysi Malkoc; Natalia Higuita-Castro; Surya Gnyawali; Lingqian Chang; Wei-Ching Liao; Junfeng Shi; Mithun Sinha; Kanhaiya Singh; Erin Steen; Alec Sunyecz; Richard Stewart; Jordan Moore; Thomas Ziebro; Robert G Northcutt; Michael Homsy; Paul Bertani; Wu Lu; Sashwati Roy; Savita Khanna; Cameron Rink; Vishnu Baba Sundaresan; Jose J Otero; L James Lee; Chandan K Sen
Journal:  Nat Nanotechnol       Date:  2017-08-07       Impact factor: 39.213

9.  Vascular Regeneration With New Sources of Endothelial Cells.

Authors:  Sangho Lee; Shin-Jeong Lee; Young-Sup Yoon
Journal:  Circ Res       Date:  2019-01-04       Impact factor: 17.367

Review 10.  Etv2 as an essential regulator of mesodermal lineage development.

Authors:  Naoko Koyano-Nakagawa; Daniel J Garry
Journal:  Cardiovasc Res       Date:  2017-09-01       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.